PR-ATTACHMENT 1-TECHNICAL-Product and Organization Details 7-25-2022.xlsx

XLSX spreadsheet 18 KB Posted

Attached to
75A50322Q00019 SNS Pharmaceutical Buy
Solicitation number
75A50322Q00019
Issued by
Not on record

About this file

This is a summary of a solicitation for a Strategic National Stockpile pharmaceutical buy. The solicitation seeks offers for bulk pharmaceuticals to be purchased by the Division of Strategic National Stockpile within the Department of Health and Human Services. Offerors are directed to submit pricing and technical proposals by August 23, 2022 responding to requirements for various pharmaceutical products listed in an attached technical file. The period of performance is one year starting September 30, 2022. The solicitation will result in multiple contract awards, with the government intending to award its entire 12-month quantity for each pharmaceutical to a single offeror. Questions are due by August 12, 2022 and the point of contact is the contracting officer.

View the file

Other files

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

ATTACHMENT 1- TECHNICAL INFO

TECHNICAL ATTACHMENT-1
Company NameBusiness SizeItem No.Product DescriptionNDC #Quantity in EachesUnit of Measure (UoM)Eaches Per UOMOrganization Type: Manufacturer or Authorized ResellerFDA Approved Shelf-LifeShelf-Life at Time of DeliveryDEA License # (Controlled Substances Only)Delivery ScheduleOct-22Nov-22Dec-22Jan-23Feb-23Mar-23Apr-23May-23Jun-23Jul-23Aug-23Sep-23
1Albuterol Nebulizer Solution, 0.083% - 2.5mg/3ml vial2,460
2Atropine 0.4mg/ml x 20ml soln., 0.4mg/ml x 20ml soln. inj. multi-dose vial 8mg495,000
3Bacitracin zinc, (500u/gm) ointment 30gm tube33,048
4Bacitracin, 500u/Polymixin 10000u, 3.5gm, opthalmic160,144
5Bactrim sulfamethoxazole, 800mg/trimethoprim 160mg tablets316,800
6Ciprofloxacin, 250mg/5ml oral suspension, powder, 100ml bottle4,440,168
7Clindamycin phosphate, 150mg/cc in 6cc vial1,441,125
8Clindamycin, HCL Oral Capsules, USP 300mg5,247,360
9Dextrose, 5% and .45% Sodium Chloride for injection, 1000ml solution bag14,210
10Diazepam soln. for inj., 5mg/ml, x 10ml multi-dose vial20,000
11Dopamine HCL solution, for injection, 400mg (40mg/ml) in a 10ml vial49,050
12Doxycycline 25mg/5ml oral suspension, powder, 60ml bottle171,312
13Levophed (Norepinephrine), 1mg/ml in 4ml amp5,400
14Lidocaine 1% with Epinephrine 30ml vial8,300
15Methylprednisolone sodium succinate for injection,125mg, 2ml powder/diluent 2 chamber vial9,900
16Morphine Sulfate, 10mg/ml, 1ml, LL(luer-loc) pre-filled syringe1,408,700
17Oxycodone HCL 5mg/Acetaminophen 325mg Tab2,315,500
18Penicillin G Potassium 20MU266,000
19Polymyxin B sulfate/bacitracin zinc double antibiotic ointment, 0.9gm foil packet70,992
20Potassium Chloride solution for injection, 2mEq/ml, 20ml vial69,300
21Proparacaine (Hydrochloride Ophthalmic Solution) USP 0.5% 15ML Sterile43,264
22Rifampin 600mg/vial for injection87,900
23Saline (sodium chloride) flush 3ml in a 10ml diameter syringe, prefilled6,122,400
24Sodium Chloride (NaCL) 0.9% for injection, 100ml solution flexi-bag6,595,680
25Sterile water for injection, preservative free, 10ml solution vial480,800
26Voriconazole 200mg Tablet197,640
27Xylocaine (Lidocaine) HCL MPF 1% without Epinephrine injection, 50ml (10mg/ml) in a 5 ml solution vial28,400

Past Performance

Project 1
Contract #
Customer/Agency Name
Contract Title
Contract Type
Period of Performance
Value
Product Name
Quantity
Brief narrative description of the work performed, including a description of how the previous work demonstrates the Offeror’s capacity to successfully meet the requirements described in the request for proposal (RFQ) and a discussion of any problems encountered/corrective actions and significant accomplishments
Project 2
Contract #
Customer/Agency Name
Contract Title
Contract Type
Period of Performance
Value
Product Name
Quantity
Brief narrative description of the work performed, including a description of how the previous work demonstrates the Offeror’s capacity to successfully meet the requirements described in the request for proposal (RFQ) and a discussion of any problems encountered/corrective actions and significant accomplishments

File details come from the government source that posted it. Updated .